FIBROGEN INC — Director's Dealing 2016

Nov 19, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2016-11-17

Reporting Person: KEARNS THOMAS F JR (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-17	Common Stock	M	5000	$4.025	Acquired	165564	Direct
2016-11-17	Common Stock	S	5000	$22.2056	Disposed	160564	Direct
2016-11-18	Common Stock	M	13000	$4.025	Acquired	173564	Direct
2016-11-18	Common Stock	S	13000	$22.4717	Disposed	160564	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-11-17	Stock Option (Right to Buy)	$4.025	M	5000	Disposed	2017-08-19	Common Stock (5000)	Direct
2016-11-18	Stock Option (Right to Buy)	$4.025	M	7000	Disposed	2017-08-19	Common Stock (7000)	Direct
2016-11-18	Stock Option (Right to Buy)	$4.025	M	6000	Disposed	2017-08-19	Common Stock (6000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	110000	Indirect

Footnotes

F1: The shares were sold at prices ranging from $22.10 to $22.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F2: The shares were sold at prices ranging from $22.35 to $22.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Fully vested.